Rheumatology International

Papers
(The median citation count of Rheumatology International is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt107
A hypothetical future in rheumatology: will we miss steroids in a steroid free-world?79
Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study78
COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review72
Cardiac involvement in primary Sjӧgren’s syndrome65
Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review54
COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis52
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed51
Epidemiology and genetics of granulomatosis with polyangiitis50
Risk factors of avascular necrosis in Takayasu arteritis: a cross sectional study49
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR43
Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren’s syndrome39
Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study39
Clonal expansion of large granular lymphocytes in patients with spondyloarthritis and psoriatic arthritis treated with TNFα inhibitors36
Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study35
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases34
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study33
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly30
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews25
Assessment of sarcopenia in patients with fibromyalgia25
Alternatives for erroneous finger probe pulse oximetry in systemic sclerosis patients during COVID-19 pandemic24
Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 201723
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review23
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort22
Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound21
Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review20
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis20
Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet’s disease, and iBCG-induced ReA20
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination20
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey20
Resilience in women with primary Sjögren’s syndrome19
Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes19
Association of extended myositis panel results, clinical features, and diagnoses: a single-center retrospective observational study19
Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown18
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development18
Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients18
Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient17
Evaluation of Big Five personality factors in women with fibromyalgia: a cross-sectional study17
The impact of COVID-19 on familial Mediterranean fever: a nationwide study16
Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey16
The synergistic role of TNFA − 308G/A and IL10 − 1082A/G polymorphisms in ankylosing spondylitis16
Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients15
COVID-19 in patients with gout on colchicine15
Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis15
Axial spondyloarthritis and inflammatory bowel disease: association between disease activity and endothelial dysfunction markers15
Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection15
Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based review14
Clinical presentation and treatment outcomes of arterial involvement in Behçet’s disease: a single-centre experience14
COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?13
The relationship between defects in DNA repair genes and autoinflammatory diseases12
Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review12
Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study12
Telerheumatology and its interplay with patient-initiated care12
Corticosteroid monotherapy for the management of Takayasu arteritis—a systematic review and meta-analysis11
What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study11
The stratification of primary Sjogren’s syndrome: is it really solving the problem?11
Decrease in handgrip strength in rheumatoid arthritis (RA): is there a sex-related difference?10
Evaluation of the prevalence of musculoskeletal conditions in consecutive patients with skin psoriasis: a descriptive cross-sectional study10
Reactive arthritis after COVID-19: a case-based review10
A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient10
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study9
Dosage of resistance exercises in fibromyalgia: evidence synthesis for a systematic literature review up-date and meta-analysis9
The impact of the COVID-19 pandemic on patients with primary Sjögren syndrome9
Pulmonary nodular lymphoid hyperplasia and Sjögren’s syndrome: a case report and literature review9
The continuum of art and rheumatology: a discernment of mutual inclusivity9
Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry9
Rituximab and intravenous immunoglobulin treatment in PM/Scl antibody-associated disease: case-based review9
Non-disease specific patient-reported outcome measures of health-related quality of life in juvenile idiopathic arthritis: a systematic review of current research and practice9
The efficacy and safety of extracorporeal shock wave therapy on plantar fasciitis in patients with axial spondyloarthritis: a double-blind, randomized controlled trial9
In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?9
Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children9
Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study9
YouTube as a source of information on COVID-19 vaccination in rheumatic diseases8
Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis8
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials8
The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study8
Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective8
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study8
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls8
Patients with rheumatic diseases are ready to use social media in clinical practice; what about rheumatologists? A cross-sectional survey8
Fibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis8
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study8
The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey8
Emerging epigenetic targets in rheumatoid arthritis8
0.070954084396362